ArticleResearch square2026

Targeting cancer-intrinsic protein neddylation bypasses the loss of JAK/STAT signaling and overcomes acquired resistance to immunotherapy.

Yumeng Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.